{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:32:41Z","timestamp":1786984361664,"version":"build-2736575974"},"reference-count":62,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["americanjournalofsurgery.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Surgery"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1016\/j.amjsurg.2009.01.029","type":"journal-article","created":{"date-parts":[[2009,12,18]],"date-time":"2009-12-18T10:07:44Z","timestamp":1261130864000},"page":"43-51","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Heparin-induced thrombocytopenia in surgical patients"],"prefix":"10.1016","volume":"199","author":[{"given":"Sandra","family":"Battistelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Genovese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommaso","family":"Gori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjsurg.2009.01.029_bib1","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1046\/j.1365-2141.2003.04334.x","article-title":"Heparin-induced thrombocytopenia: pathogenesis and management","volume":"121","author":"Warkentin","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.amjsurg.2009.01.029_bib2","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.thromres.2005.07.012","article-title":"Recognition, treatment, and prevention of heparin-induced thrombocytopenia: review and update","volume":"118","author":"Greinacher","year":"2006","journal-title":"Thromb Res"},{"key":"10.1016\/j.amjsurg.2009.01.029_bib3","first-page":"141","article-title":"Heparin-induced thrombocytopenia","volume":"51","author":"Warkentin","year":"2005","journal-title":"Disorders"},{"key":"10.1016\/j.amjsurg.2009.01.029_bib4","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1055\/s-2004-831039","article-title":"An overview of the heparin-induced thrombocytopenia syndrome","volume":"30","author":"Warkentin","year":"2004","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.amjsurg.2009.01.029_bib5","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1056\/NEJMcp052967","article-title":"Clinical practice","volume":"355","author":"Arepally","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjsurg.2009.01.029_bib6","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1182\/blood-2004-04-1544","article-title":"Ultralarge complexes of PF4 and heparin are central to the pathogenesis of heparin-induced thrombocytopenia","volume":"105","author":"Rauova","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.amjsurg.2009.01.029_bib7","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1160\/TH04-12-0825","article-title":"Clinical features of heparin-induced thrombocytopenia including risk factors for thrombosis","volume":"94","author":"Greinacher","year":"2005","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.amjsurg.2009.01.029_bib8","series-title":"Heparin-Induced Thrombocytopenia","first-page":"67","article-title":"Frequency of heparin-induced thrombocytopenia","author":"Lee","year":"2007"},{"key":"10.1016\/j.amjsurg.2009.01.029_bib9","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1056\/NEJM200104263441704","article-title":"Temporal aspects of heparin-induced thrombocytopenia","volume":"344","author":"Warkentin","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjsurg.2009.01.029_bib10","doi-asserted-by":"crossref","first-page":"502","DOI":"10.7326\/0003-4819-135-7-200110020-00009","article-title":"Delayed-onset heparin-induced thrombocytopenia and thrombosis","volume":"135","author":"Warkentin","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.amjsurg.2009.01.029_bib11","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1182\/blood-2005-04-1546","article-title":"Risk for heparin-induced thrombocytopenia with unfractionated and low-molecular-weight heparin thromboprophylaxis: a meta-analysis","volume":"106","author":"Martel","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.amjsurg.2009.01.029_bib12","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1182\/blood-2005-11-012450","article-title":"Gender imbalance and risk factor interactions in heparin-induced thrombocytopenia","volume":"108","author":"Warkentin","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.amjsurg.2009.01.029_bib13","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.0889-7204.2005.04693.x","article-title":"Thrombocytopenia following heparin flush","volume":"20","author":"McNulty","year":"2005","journal-title":"Prog Cardiovasc Nurs"},{"key":"10.1016\/j.amjsurg.2009.01.029_bib14","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1001\/archinte.163.20.2518","article-title":"An improved definition of immune heparin-induced thrombocytopenia in postoperative orthopedic patients","volume":"163","author":"Warkentin","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.amjsurg.2009.01.029_bib15","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1182\/blood.V96.5.1703","article-title":"Impact of the patient population on the risk for heparin-induced thrombocytopenia","volume":"96","author":"Warkentin","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.amjsurg.2009.01.029_bib16","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1160\/TH03-09-0571","article-title":"Heparin-induced thrombocytopenia in children: 12 new cases and review of the literature","volume":"91","author":"Klenner","year":"2004","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.amjsurg.2009.01.029_bib17","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.thromres.2004.10.009","article-title":"Incidence of heparin-PF4 complex antibody formation and heparin-induced thrombocytopenia in acute coronary syndrome","volume":"115","author":"Matsuo","year":"2005","journal-title":"Thromb Res"},{"key":"10.1016\/j.amjsurg.2009.01.029_bib18","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1378\/chest.08-0677","article-title":"Treatment and prevention of heparin-induced thrombocytopenia: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition)","volume":"133","author":"Warkentin","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.amjsurg.2009.01.029_bib19","doi-asserted-by":"crossref","first-page":"123S","DOI":"10.1378\/chest.08-0654","article-title":"Grades of recommendation for antithrombotic agents","volume":"133","author":"Guyatt","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.amjsurg.2009.01.029_bib20","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1160\/TH03-07-0454","article-title":"Titre of anti-heparin\/PF4-antibodies and extent of in vivo activation of the coagulation and fibrinolytic systems","volume":"91","author":"Chilver-Stainer","year":"2004","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.amjsurg.2009.01.029_bib21","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.jtcvs.2005.07.052","article-title":"Preoperative anti-PF4\/heparin antibody level predicts adverse outcome after cardiac surgery","volume":"130","author":"Bennett-Guerrero","year":"2005","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.amjsurg.2009.01.029_bib22","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S0741-5214(99)70203-X","article-title":"The role of heparin-associated antiplatelet antibodies in the outcome of arterial reconstruction","volume":"29","author":"Calaitges","year":"1999","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.amjsurg.2009.01.029_bib23","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1182\/blood-2005-05-1824","article-title":"Replacement of unfractionated heparin by low-molecular-weight heparin for postorthopedic surgery antithrombotic prophylaxis lowers the overall risk of symptomatic thrombosis because of a lower frequency of heparin-induced thrombocytopenia","volume":"106","author":"Greinacher","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.amjsurg.2009.01.029_bib24","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1001\/archinte.164.4.361","article-title":"Treatment of heparin-induced thrombocytopenia: a critical review","volume":"164","author":"Hirsh","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.amjsurg.2009.01.029_bib25","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1182\/blood-2002-05-1448","article-title":"Central venous catheters and upper-extremity deep-vein thrombosis complicating immune heparin-induced thrombocytopenia","volume":"101","author":"Hong","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.amjsurg.2009.01.029_bib26","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1378\/chest.129.6.1407","article-title":"Effects of argatroban therapy, demographic variables, and platelet count on thrombotic risks in heparin-induced thrombocytopenia","volume":"129","author":"Lewis","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.amjsurg.2009.01.029_bib27","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1046\/j.1365-2796.2002.01021.x","article-title":"Risk factors for thrombosis in patients with immune mediated heparin-induced thrombocytopenia","volume":"252","author":"Fabris","year":"2002","journal-title":"J Intern Med"},{"key":"10.1016\/j.amjsurg.2009.01.029_bib28","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/ajh.20098","article-title":"Risk of thrombosis in patients with malignancy and heparin-induced thrombocytopenia","volume":"76","author":"Opatrny","year":"2004","journal-title":"Am J Hematol"},{"key":"10.1016\/j.amjsurg.2009.01.029_bib29","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/S0002-9343(96)00258-6","article-title":"14-year study of heparin-induced thrombocytopenia","volume":"101","author":"Warkentin","year":"1996","journal-title":"Am J Med"},{"key":"10.1016\/j.amjsurg.2009.01.029_bib30","series-title":"Heparin-Induced Thrombocytopenia","first-page":"21","article-title":"Clinical picture of heparin-induced thrombocytopenia","author":"Workentin","year":"2007"},{"key":"10.1016\/j.amjsurg.2009.01.029_bib31","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1046\/j.1365-2141.1996.d01-1481.x","article-title":"Heparin-induced skin lesions","volume":"92","author":"Warkentin","year":"1996","journal-title":"Br J Haematol"},{"issue":"suppl","key":"10.1016\/j.amjsurg.2009.01.029_bib32","doi-asserted-by":"crossref","first-page":"35S","DOI":"10.1378\/chest.127.2_suppl.35S","article-title":"New approaches to the diagnosis of heparin-induced thrombocytopenia","volume":"127","author":"Warkentin","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.amjsurg.2009.01.029_bib33","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1161\/01.CIR.103.14.1838","article-title":"Argatroban anticoagulant therapy in patients with heparin-induced thrombocytopenia","volume":"103","author":"Lewis","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.amjsurg.2009.01.029_bib34","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1111\/j.1538-7836.2005.01623.x","article-title":"Lepirudin in patients with heparin-induced thrombocytopenia\u2014results of the third prospective study (HAT-3) and a combined analysis of HAT-1, HAT-2, and HAT-3","volume":"3","author":"Lubenow","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.amjsurg.2009.01.029_bib35","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1111\/j.1538-7836.2006.01787.x","article-title":"Evaluation of pretest clinical score (4 T's) for the diagnosis of heparin-induced thrombocytopenia in two clinical settings","volume":"4","author":"Lo","year":"2006","journal-title":"J Thromb Haemost"},{"issue":"suppl 1","key":"10.1016\/j.amjsurg.2009.01.029_bib36","first-page":"43","article-title":"Laboratory tests for the diagnosis of heparin-induced thrombocytopenia","volume":"25","author":"Walenga","year":"1999","journal-title":"Semin Thromb Hemost"},{"issue":"suppl 1","key":"10.1016\/j.amjsurg.2009.01.029_bib37","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1177\/10760296990050S105","article-title":"Laboratory diagnosis of heparin-induced thrombocytopenia","volume":"5","author":"Walenga","year":"1999","journal-title":"Clin Appl Thromb\/Hemost"},{"key":"10.1016\/j.amjsurg.2009.01.029_bib38","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.tmrv.2006.05.001","article-title":"Testing for heparin-induced thrombocytopenia antibodies","volume":"20","author":"Warkentin","year":"2006","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.amjsurg.2009.01.029_bib39","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1161\/01.CIR.100.6.587","article-title":"Lepirudin (recombinant hirudin) for parenteral anticoagulation in patients with heparin-induced thrombocytopenia","volume":"100","author":"Greinacher","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.amjsurg.2009.01.029_bib40","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1161\/01.CIR.99.1.73","article-title":"Recombinant hirudin (lepirudin) provides safe and effective anticoagulation in patients with heparin-induced thrombocytopenia: a prospective study","volume":"99","author":"Greinacher","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.amjsurg.2009.01.029_bib41","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1182\/blood-2006-02-001057","article-title":"Predictive factors for thrombosis and major bleeding in an observational study in 181 patients with heparin-induced thrombocytopenia treated with lepirudin","volume":"108","author":"Tardy","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.amjsurg.2009.01.029_bib42","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1161\/01.CIR.0000096056.37269.14","article-title":"Anaphylactic and anaphylactoid reactions associated with lepirudin in patients with heparin-induced thrombocytopenia","volume":"108","author":"Greinacher","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.amjsurg.2009.01.029_bib43","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1182\/blood.V96.7.2373","article-title":"Antihirudin antibodies in patients with heparin-induced thrombocytopenia treated with lepirudin: incidence, effects on APTT, and clinical relevance","volume":"96","author":"Eichler","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.amjsurg.2009.01.029_bib44","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1001\/archinte.163.15.1849","article-title":"Argatroban anticoagulation in patients with heparin-induced thrombocytopenia","volume":"163","author":"Lewis","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.amjsurg.2009.01.029_bib45","first-page":"611","article-title":"The anticoagulant therapy with bivalirudin to assist in the performance of percutaneous coronary intervention in patients with heparin-induced thrombocytopenia (ATBAT) study: main results","volume":"15","author":"Mahaffey","year":"2003","journal-title":"J Invasive Cardiol"},{"key":"10.1016\/j.amjsurg.2009.01.029_bib46","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1056\/NEJMoa062437","article-title":"Bivalirudin for patients with acute coronary syndromes","volume":"355","author":"Stone","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjsurg.2009.01.029_bib47","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1160\/TH05-07-0489","article-title":"Heparin-induced thrombocytopenia (HIT)","volume":"95","author":"Magnani","year":"2006","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.amjsurg.2009.01.029_bib48","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1055\/s-0037-1616046","article-title":"Prospective randomised open-label comparison of danaparoid with dextran 70 in the treatment of heparin-induced thrombocytopaenia with thrombosis: a clinical outcome study","volume":"86","author":"Chong","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.amjsurg.2009.01.029_bib49","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1055\/s-0037-1615946","article-title":"A comparison of danaparoid and lepirudin in heparin-induced thrombocytopenia","volume":"85","author":"Farner","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.amjsurg.2009.01.029_bib50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0049-3848(97)00042-X","article-title":"Biochemical and pharmacologic rationale for the development of a synthetic heparin pentasaccharide","volume":"86","author":"Walenga","year":"1997","journal-title":"Thromb Res"},{"key":"10.1016\/j.amjsurg.2009.01.029_bib51","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1021\/jm960726z","article-title":"Synthesis and pharmacological properties of a close analogue of an antithrombotic pentasaccharide","volume":"40","author":"Petitou","year":"1997","journal-title":"J Med Chem"},{"key":"10.1016\/j.amjsurg.2009.01.029_bib52","doi-asserted-by":"crossref","first-page":"3791","DOI":"10.1182\/blood-2005-05-1938","article-title":"Anti-platelet factor 4\/heparin antibodies in orthopedic surgery patients receiving antithrombotic prophylaxis with fondaparinux or enoxaparin","volume":"106","author":"Warkentin","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.amjsurg.2009.01.029_bib53","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/00001721-199703000-00005","article-title":"Absence of cross-reactivity of SR90107A\/ORG31540 pentasaccharide with antibodies to heparin-PF4 complexes developed in heparin-induced thrombocytopenia","volume":"8","author":"Amiral","year":"1997","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.amjsurg.2009.01.029_bib54","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1177\/107602969900500410","article-title":"Synthetic pentasaccharides do not cause platelet activation by antiheparin-platelet factor 4 antibodies","volume":"5","author":"Ahmad","year":"1999","journal-title":"Clin Appl Thromb\/Hemost"},{"key":"10.1016\/j.amjsurg.2009.01.029_bib55","first-page":"1017","article-title":"Treatment of heparin-induced thrombocytopenia with fondaparinux","volume":"89","author":"Harenberg","year":"2004","journal-title":"Haematologica"},{"key":"10.1016\/j.amjsurg.2009.01.029_bib56","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1182\/blood.V104.11.1775.1775","article-title":"Fondaparinux in the treatment of heparin-induced thrombocytopenia","volume":"104","author":"Bradner","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.amjsurg.2009.01.029_bib57","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1160\/TH07-04-0252","article-title":"Fondaparinux for the treatment of patients with acute heparin-induced thrombocytopenia","volume":"99","author":"Lobo","year":"2008","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.amjsurg.2009.01.029_bib58","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1055\/s-0037-1616573","article-title":"Successful treatment of heparin induced thrombocytopenia (HIT) with fondaparinux","volume":"93","author":"Kovacs","year":"2005","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.amjsurg.2009.01.029_bib59","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1213\/01.ANE.0000114072.71353.D5","article-title":"Reversal of direct thrombin inhibition after cardiopulmonary bypass in a patient with heparin-induced thrombocytopenia","volume":"98","author":"Stratmann","year":"2004","journal-title":"Anesth Analg"},{"key":"10.1016\/j.amjsurg.2009.01.029_bib60","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1161\/01.CIR.0000038501.87442.02","article-title":"Ability of recombinant factor VIIa to reverse the anticoagulant effect of the pentasaccharide fondaparinux in healthy volunteers","volume":"106","author":"Bijsterveld","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.amjsurg.2009.01.029_bib61","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1345\/aph.1G494","article-title":"Successful recovery from an overdose of argatroban","volume":"40","author":"Yee","year":"2006","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.amjsurg.2009.01.029_bib62","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1001\/archinte.164.18.1961","article-title":"Heparin-induced thrombocytopenia: myths and misconceptions (that will cause trouble for you and your patient)","volume":"164","author":"Rice","year":"2004","journal-title":"Arch Intern Med"}],"container-title":["The American Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000296100900261X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000296100900261X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T17:54:54Z","timestamp":1757699694000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000296100900261X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":62,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["S000296100900261X"],"URL":"https:\/\/doi.org\/10.1016\/j.amjsurg.2009.01.029","relation":{},"ISSN":["0002-9610"],"issn-type":[{"value":"0002-9610","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Heparin-induced thrombocytopenia in surgical patients","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjsurg.2009.01.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}